[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fX4CF0PwzrjdI6eHddPwvOZU4g1WzoFr27m3zPD6oeNQ":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":12,"question":19,"related":20,"source":24,"type":25},[],"2026-01-06 14:11:36",304545673,[8,9,10,11],"确保项目正常进行","保障受试者安全","确保治疗效果","合理控制成本",{"count":13,"courseId":14,"courseImg":15,"courseName":16,"workId":17,"workName":18},70,"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","exam_168773854","GCP检测","规范化管理试验用药品的意义",[21,26,35,44,53,62,72,81,90,100],{"answer":22,"createTime":5,"id":6,"options":23,"question":19,"source":24,"type":25},[],[8,9,10,11],"v1",1,{"answer":27,"createTime":5,"id":28,"options":29,"question":34,"source":24,"type":25},[],304545674,[30,31,32,33],"适应证","试验用药品","试验目的","试验设计","试验方案名称包含的信息有( )",{"answer":36,"createTime":5,"id":37,"options":38,"question":43,"source":24,"type":25},[],304545675,[39,40,41,42],"GSP-----药品经营质量管理规范","GMP----药品生产质量管理规范","GCP---药物临床试验质量管理规范","GVP-----药物警戒质量管理规范","下列缩写与中文名称对应正确的有( )",{"answer":45,"createTime":5,"id":46,"options":47,"question":52,"source":24,"type":25},[],304545676,[48,49,50,51],"充分理解","书面签署","完全告知","自主选择","知情同意的准则有( )",{"answer":54,"createTime":5,"id":55,"options":56,"question":61,"source":24,"type":25},[],304545677,[57,58,59,60],"填写病例报告表","处理剩余的试验用药品","做出相关的医疗决定","报告不良事件","下列属于研究者的职责的是( )",{"answer":63,"createTime":5,"id":64,"options":65,"question":71,"source":24,"type":25},[],304545678,[66,67,68,69,70],"参与病例报告表的填写","以谈话形式对受试者进行知情同意","保证临床试验按照试验方案、标准操作规程和相关法律法规要求实施、记录和报告","预约接待受试者","每次监查后,应当及时书面报告申办者","关于CRA的职责,下述说法正确的是( )",{"answer":73,"createTime":5,"id":74,"options":75,"question":80,"source":24,"type":25},[],304545679,[76,77,78,79],"研究者发起的临床研究","医疗器械临床试验","药物临床试验","新医疗新技术研究项目","以下需要伦理审查的项目有( )",{"answer":82,"createTime":5,"id":83,"options":84,"question":89,"source":24,"type":25},[],304545680,[32,85,86,87,88],"研究资料的归档要求","参加该试验的预计受试者人数","研究者的专业资格和经验","试验预期的受益和可能发生的风险","下列属于知情同意书必需的内容的是( )",{"answer":91,"createTime":5,"id":92,"options":93,"question":99,"source":24,"type":25},[],304545681,[94,95,96,97,98],"项目研讨会","项目设计","项目立项","项目结束","项目运行","药物临床试验开展的流程包括( )",{"answer":101,"createTime":5,"id":102,"options":103,"question":108,"source":24,"type":25},[],304545682,[104,105,106,107],"如果父母同意参加临床试验并签署,该学生不签署即可参加","如果该学生不愿意参加,父母也需要尊重其意见","需要学生和父母同时进行签署","已有阅读签署能力自行签署即可","11岁学生参加临床试验签署知情同意书时注意( )"]